Phenominer Database Results (52 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
BN/Cub body weight controlled sucrose content diet (for 7 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 307 days 6 291.1 g 10.29 25.2 body weighing method 0.0 0 70208 1318
PD/Cub serum triglyceride level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 300 days 6 178.76 mg/dl 18.06 44.25 liquid phase colorimetry retroorbital plexus 0.0 0 70213 1318
PD/Cub liver weight to body weight ratio controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. liver mass male 310 days 6 41.7 g/kg 0.82 2.0 post excision weight measurement 0.0 0 70217 1318
PD/Cub blood glucose level area under curve (AUC) fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 300 days 6 15152.73 (mg/dl) x min 298.39 730.91 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70268 1318
BN/Cub serum insulin level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 300 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70275 1318
BN/Cub serum uric acid level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 307 days 6 101.8 umol/l 4.78 11.7 liquid phase colorimetry retroorbital plexus 0.0 0 70283 1318
BN/Cub serum glucose level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 307 days 6 74.42 mg/dl 3.7 9.07 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70239 1318
BN/Cub serum free fatty acids level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 300 days 6 1.12 mmol/l 0.08 0.2 liquid phase colorimetry retroorbital plexus 0.0 0 70229 1318
BN/Cub body weight control condition Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 300 days 6 274.1 g 8.37 20.5 body weighing method 0.0 0 70206 1318
PD/Cub heart weight to body weight ratio controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. heart mass male 310 days 6 3.4 g/kg 0.41 1.0 post excision weight measurement 0.0 0 70209 1318
PD/Cub body weight controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 310 days 6 352.9 g 1.55 3.8 body weighing method 0.0 0 70211 1318
BN/Cub serum triglyceride level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 300 days 6 47.79 mg/dl 3.61 8.85 liquid phase colorimetry retroorbital plexus 0.0 0 70214 1318
PD/Cub serum triglyceride level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 310 days 6 2412.4 mg/dl 173.42 424.78 liquid phase colorimetry retroorbital plexus 0.0 0 70219 1318
BN/Cub serum triglyceride level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 310 days 6 46.9 mg/dl 3.61 8.85 liquid phase colorimetry retroorbital plexus 0.0 0 70220 1318
BN/Cub serum uric acid level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 300 days 6 72.3 umol/l 1.55 3.8 liquid phase colorimetry retroorbital plexus 0.0 0 70281 1318
PD/Cub blood glucose level area under curve (AUC) controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 307 days 6 15169.09 (mg/dl) x min 239.01 585.45 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70270 1318
PD/Cub single kidney wet weight to body weight ratio controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. kidney mass male 310 days 6 3.8 g/kg 0.04 0.1 post excision weight measurement 0.0 0 70286 1318
BN/Cub serum glucose level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 300 days 6 78.05 mg/dl 1.48 3.63 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70237 1318
PD/Cub serum glucose level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 310 days 6 375.71 mg/dl 12.6 30.86 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70240 1318
PD/Cub serum triglyceride level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 307 days 6 276.99 mg/dl 43.35 106.2 liquid phase colorimetry retroorbital plexus 0.0 0 70215 1318
BN/Cub serum free fatty acids level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 307 days 6 1.26 mmol/l 0.08 0.2 liquid phase colorimetry retroorbital plexus 0.0 0 70231 1318
BN/Cub epididymal fat pad weight to body weight ratio controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. epididymal fat pad mass male 310 days 6 fat pad weight/100g body weight 0.78 % 0.04 0.1 post excision weight measurement 0.0 0 70233 1318
PD/Cub serum free fatty acids level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 310 days 6 4.13 mmol/l 0.12 0.3 liquid phase colorimetry retroorbital plexus 0.0 0 70234 1318
BN/Cub blood glucose level area under curve (AUC) controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 310 days 6 42156.36 (mg/dl) x min 1723.55 4221.82 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70273 1318
SHR.PD-(D8Mgh9-D8Rat149)/Cub serum free fatty acids level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 0 days 6 1.58 mmol/l 0.04 0.09 liquid phase colorimetry retroorbital plexus 0.0 0 70289 1318
PD/Cub body weight control condition Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 300 days 6 376.9 g 3.02 7.4 body weighing method 0.0 0 70205 1318
BN/Cub serum triglyceride level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood triglyceride amount male 307 days 6 61.95 mg/dl 7.23 17.7 liquid phase colorimetry retroorbital plexus 0.0 0 70216 1318
PD/Cub serum insulin level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 300 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70274 1318
BN/Cub serum insulin level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 310 days 6 0.08 mg/dl 0.02 0.04 radioimmunoassay retroorbital plexus 0.0 0 70279 1318
PD/Cub serum glucose level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 300 days 6 94.38 mg/dl 2.96 7.26 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70236 1318
BN/Cub serum glucose level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 310 days 6 252.29 mg/dl 28.16 68.97 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70241 1318
BN/Cub body weight controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 310 days 6 257.6 g 10.29 25.2 body weighing method 0.0 0 70212 1318
BN/Cub liver weight to body weight ratio controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. liver mass male 310 days 6 35.7 g/kg 1.63 4.0 post excision weight measurement 0.0 0 70218 1318
BN/Cub blood glucose level area under curve (AUC) fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 300 days 6 14454.55 (mg/dl) x min 247.18 605.45 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70269 1318
PD/Cub blood glucose level area under curve (AUC) controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 310 days 6 57081.82 (mg/dl) x min 512.91 1256.36 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70272 1318
SHR/OlaIpcv serum free fatty acids level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 0 days 6 1.28 mmol/l 0.02 0.04 liquid phase colorimetry retroorbital plexus 0.0 0 70288 1318
PD/Cub serum free fatty acids level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 307 days 6 1.56 mmol/l 0.04 0.1 liquid phase colorimetry retroorbital plexus 0.0 0 70230 1318
PD/Cub serum glucose level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 307 days 6 88.94 mg/dl 1.48 3.63 oral glucose tolerance test tail vein 0.0 intragastric glucose 0 min 70238 1318
PD/Cub body weight controlled sucrose content diet (for 7 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 307 days 6 398.0 g 0.86 2.1 body weighing method 0.0 0 70207 1318
BN/Cub heart weight to body weight ratio controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. heart mass male 310 days 6 3.6 g/kg 0.04 0.1 post excision weight measurement 0.0 0 70210 1318
PD/Cub epididymal fat pad weight to body weight ratio controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. epididymal fat pad mass male 310 days 6 fat pad weight/100g body weight 2.17 % 0.08 0.2 post excision weight measurement 0.0 0 70232 1318
PD/Cub serum insulin level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 307 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70276 1318
BN/Cub serum insulin level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 307 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70277 1318
PD/Cub serum insulin level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 310 days 6 0.12 mg/dl 0.0 0.01 radioimmunoassay retroorbital plexus 0.0 0 70278 1318
PD/Cub serum uric acid level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 300 days 6 66.6 umol/l 0.57 1.4 liquid phase colorimetry retroorbital plexus 0.0 0 70280 1318
PD/Cub serum uric acid level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 307 days 6 110.2 umol/l 2.49 6.1 liquid phase colorimetry retroorbital plexus 0.0 0 70282 1318
PD/Cub serum uric acid level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 310 days 6 67.2 umol/l 2.53 6.2 liquid phase colorimetry retroorbital plexus 0.0 0 70284 1318
BN/Cub serum uric acid level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood uric acid amount male 310 days 6 107.3 umol/l 3.18 7.8 liquid phase colorimetry retroorbital plexus 0.0 0 70285 1318
PD/Cub serum free fatty acids level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 300 days 6 1.05 mmol/l 0.04 0.1 liquid phase colorimetry retroorbital plexus 0.0 0 70228 1318
BN/Cub blood glucose level area under curve (AUC) controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood glucose amount male 307 days 6 15850.91 (mg/dl) x min 1065.16 2609.09 oral glucose tolerance test tail vein 0.0 intragastric glucose 120 min 70271 1318
BN/Cub single kidney wet weight to body weight ratio controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. kidney mass male 310 days 6 3.0 g/kg 0.04 0.1 post excision weight measurement 0.0 0 70287 1318
BN/Cub serum free fatty acids level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood free fatty acid amount male 310 days 6 1.4 mmol/l 0.08 0.2 liquid phase colorimetry retroorbital plexus 0.0 0 70235 1318